Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 625 | 657 | 603 | 385 | 0 |
| Cost of Goods | 443 | 398 | 494 | 150 | N/A |
| Gross Profit | 182 | 259 | 109 | 236 | N/A |
| Operating Expenses | 6,291 | 5,651 | 4,902 | 5,826 | 2,780 |
| Operating Income | -5,666 | -4,994 | -4,299 | -5,440 | -2,780 |
| Other Income | 501 | 19 | 12 | -9 | 0 |
| Pre-tax Income | -5,166 | -4,974 | -4,286 | -5,449 | -2,780 |
| Income Tax | -23 | 52 | 1 | N/A | N/A |
| Net Income Continuous | -5,142 | -5,027 | -4,287 | -5,449 | -2,780 |
| Net Income Discontinuous | N/A | N/A | N/A | -82 | -43 |
| Net Income | $-5,142 | $-5,027 | $-4,287 | $-5,531 | $-2,823 |
| EPS Basic Total Ops | -0.44 | -0.44 | -0.39 | -0.57 | -0.31 |
| EPS Basic Continuous Ops | -0.44 | -0.44 | -0.39 | -0.59 | -0.30 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.01 | 0.00 |
| EPS Diluted Total Ops | -0.44 | -0.44 | -0.39 | -0.57 | -0.31 |
| EPS Diluted Continuous Ops | -0.44 | -0.44 | -0.39 | -0.59 | -0.30 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.01 | 0.00 |
| EBITDA(a) | $-5,057 | $-4,504 | $-3,860 | $-4,996 | $-2,535 |